On December 24, Gelonghui reported that Shenzhen Genvict Technologies (002869.SZ) announced that in view of the company's overall strategic layout and its own Business development needs, Shenzhen Genvict Technologies Co., Ltd. intends to jointly invest with Ningxia Tianbao Holdings Group Co., Ltd. (referred to as "Ningxia Tianbao"), Shenzhen Qianhai Chemi Yuntu Asia Vets Co., Ltd. (referred to as "Chemi Yuntu Asia Vets"), and Shenzhen Qianhai Chemi Changqing Enterprise Management Co., Ltd. (referred to as "Chemi Changqing") to establish Ningxia Chemi Yuntu Technology Co., Ltd. (tentative name, final approval to be based on the registration by the market supervision and management department, referred to as "joint venture company" or "symbol company") in Yinchuan, Ningxia, and recently signed the "Investment Cooperation Agreement".
The registered capital of the joint venture company is proposed to be 10 million yuan, among which Ningxia Tianbao intends to subscribe for 4 million yuan, accounting for 40% of the subscription; Chemi Yuntu Asia Vets intends to subscribe for 3 million yuan, accounting for 30% of the subscription; the company intends to subscribe for 2 million yuan, accounting for 20% of the subscription; and Chemi Changqing intends to subscribe for 1 million yuan, accounting for 10% of the subscription.
